Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Medium-term impact of COVID-19 revealed in new study

Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus.

Oxford scientists develop extremely rapid diagnostic test for Covid-19

Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.

Three Oxford researchers win top UKRI Future Leaders Fellowships

Three Oxford academics have today been awarded major financial backing with UKRI Future Leaders Fellowships – for their ‘world-class research and innovation’ into space flight, high risk pregnancy and finding answers to chaotic public out-sourcing.

Oxford academics recognised in 2020 Queen’s Birthday Honours

The pioneering work of members of the University has been recognised in The Queen's Birthday Honours List

Role-playing computer game helps players understand how vaccines work on a global scale

A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.

Research emphasises need for COVID-19 vigilance in tight-knit communities

Small, close-knit communities are at high risk for rapid, intense COVID outbreaks especially if they haven’t yet experienced outbreaks of COVID-19, shows a new study by the University of Oxford and Northeastern University, Boston.

Tiny brain “tweezers” could hold the key to treating Parkinson’s Disease

A collaborative study led by the Oxford Parkinson's Disease Centre's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.

New partnership with King Abdulaziz University aims to revolutionise drug discovery using artificial intelligence

The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.

New trial to treat Covid-19 in care homes using anti-TNF drug begins

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.

Load More